So we are expanding beyond biliary tract cancer into metastatic head and neck squamous cell cancer?
Dr Google: The prognosis of patients with recurrent or metastatic head and neck squamous cell cancer is generally poor. The median survival in most series is 6 to 15 months depending on patient- and disease-related factors.
So we are expanding beyond biliary tract cancer into metastatic...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $394.1M | |||
| Open | High | Low | Value | Volume |
| 5.4¢ | 5.5¢ | 5.3¢ | $817.0K | 15.17M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 4719788 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 453183 | 5 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |